Month: March 2021

AUSTIN, Texas, March 29, 2021 (GLOBE NEWSWIRE) — Open Lending Corporation, (“Open Lending”) (Nasdaq: LPRO), a leading provider of lending enablement and risk analytics solutions to financial institutions, announced today the launch of a secondary public offering of 7,500,000 shares of its common stock. The selling stockholders have also granted the underwriters a 30-day option to purchase up to 1,125,000 additional shares of common stock. All shares are being sold by existing stockholders, including Nebula Holdings, LLC., a True Wind Capital, L.P. managed entity, Bregal Sagemount and certain executive officers of Open Lending. Open Lending is not selling any shares and will not receive any of the proceeds of the offering. Deutsche Bank Securities, Goldman Sachs & Co. LLC and Morgan Stanley are acting as joint book-running managers...

PLANO, Texas, March 29, 2021 (GLOBE NEWSWIRE) — Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” or “we”), a clinical-stage biopharmaceutical company, today announced that abstracts highlighting clinical data for bardoxolone methyl (“bardoxolone”) will be presented at two upcoming nephrology conferences including The World Congress of Nephrology 2021 being held virtually from April 15 – 19, 2021 and the 58th European Renal Association and European Dialysis and Transplant Association (“ERA-EDTA”) Congress being held from June 5 – 8, 2021 in Berlin, Germany and virtually. The poster presentation at The World Congress of Nephrology 2021 will report results from EAGLE, an open-label, long-term extension study of bardoxolone in patients with chronic kidney disease (“CKD”) caused by Alport syndrome. Abstract Title:...

When: Tuesday, March 30th, 2pm Pacific/5pm EasternWhere: Zoom webinar, RSVP https://ucr.zoom.us/webinar/register/WN_X-iGxJgeTiOrmJuI2KGUcw SAN MATEO, Calif., March 29, 2021 (GLOBE NEWSWIRE) — This presentation will focus on survey data collected in the immediate aftermath of the 2021 March Atlanta shootings. They survey asked American residents, including Asian Americans and Pacific Islanders (AAPIs), about experiences with hate crimes, harassment, and bias. The presentation materials are based on responses from a national sample of 16,336 Americans, with an oversample of Asian Americans (n=1831) and Native Hawaiian and Pacific Islanders (n=186). Representatives from AAPI Data and SurveyMonkey, as well as AAPI community partners, will discuss the following trends and more, with attention to current AAPI experiences with discrimination...

REGINA, Saskatchewan, March 29, 2021 (GLOBE NEWSWIRE) — Information Services Corporation (TSX:ISV) (“ISC” or the “Company”) is pleased to announce in has been named to the Globe and Mail’s 2021 Report on Business Women Lead Here list for the second consecutive year. Launched in 2020, Women Lead Here is a benchmark report produced by Report on Business magazine. It uses a proprietary research methodology to rank Canadian companies that have achieved, or are nearing, gender parity in executive ranks. “ISC is proud to be included among the 2021 Women Lead Here honourees,” said Jeff Stusek, President & CEO. “I am also proud that 50 per cent of the senior leadership roles at ISC are held by women from across the business. They set the standard for our organization every day and have been critical to our success. I have no doubt...

CE COMMUNIQUE NE PEUT ETRE ENVOYE, PUBLIE OU DISTRIBUE, DIRECTEMENT OU INDIRECTEMENT, AUX ETATS-UNIS, EN AUSTRALIE, AU CANADA OU AU JAPON. CE COMMUNIQUE NE CONSTITUE PAS UN DOCUMENT D’OFFRE ET A UN CARACTERE PUREMENT INFORMATIF. PARIS, 29 mars 2021 (GLOBE NEWSWIRE) — Cellectis S.A. (Nasdaq: CLLS – Euronext Growth: ALCLS), société de biotechnologie de stade clinique utilisant ses propres technologies pour développer des produits de pointes fondés sur les cellules CAR-T allogéniques ingénierées (UCART) dans le domaine de l’immuno-oncologie, annonce la mise en place ce jour d’un programme de financement en fonds propres dit « At-the-market » (le « Programme ATM ») lui permettant d’émettre et de placer auprès d’investisseurs éligibles, en une ou plusieurs fois, des actions ordinaires sous la forme d’American Depositary Shares...

DETTA PRESSMEDDELANDE FÅR INTE OFFENTLIGGÖRAS, PUBLICERAS ELLER DISTRIBUERAS, DIREKT ELLER INDIREKT, I ELLER TILL AUSTRALIEN, HONKONG, JAPAN, KANADA, NYA ZEELAND, SINGAPORE, SYDAFRIKA, USA ELLER NÅGON ANNAN JURISDIKTION DÄR SÅDAN ÅTGÄRD HELT ELLER DELVIS ÄR FÖREMÅL FÖR LEGALA RESTRIKTIONER. DETTA PRESSMEDDELANDE UTGÖR INTE ETT ERBJUDANDE OM, ELLER INBJUDAN TILL, ATT FÖRVÄRVA, ELLER TECKNA NÅGRA, VÄRDEPAPPER I CORLINE BIOMEDICAL AB I NÅGON JURISDIKTION. SE ÄVEN AVSNITTET ”VIKTIG INFORMATION” NEDAN. Pressmeddelande Corline Biomedical AB556417–07432021-03-29 Corline har genomfört en riktad emission om cirka 35,5 miljoner kronor Corline Biomedical AB (publ) (“Corline” eller “Bolaget”) har, i enlighet med vad som offentliggjordes i Bolagets pressmeddelande den 29 mars kl 17:31, framgångsrikt genomfört en riktad kontant nyemission om 3 300 000...

TORONTO, March 29, 2021 (GLOBE NEWSWIRE) — Pinehurst Capital I Inc. (TSXV: PHT.P) (the “Corporation” or “Pinehurst“), a capital pool company listed on the TSX Venture Exchange (“TSXV“), and further to its previously proposed qualifying transaction (the “Transaction“) with Silver Bullet Mines Inc. (“SBMI”), is pleased to provide an update on the Transaction and associated financing (the “SBMI Financing”). Pinehurst and SBMI made minor amendments to the definitive agreement between them. The amendments:extend the outside date to closing the Transaction to April 30, 2021; and change the definition of “SBMI Financing” to mean one or more non-brokered private placements of securities of SBMI (but, for greater certainty, excluding the SBMI Convertible Note) for aggregate gross proceeds...

PITTSBURGH, March 29, 2021 (GLOBE NEWSWIRE) — Krystal Biotech Inc., (“Krystal”) (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced participation in two upcoming virtual conferences. Details for the presentations are as follows:Guggenheim Healthcare Talks: 2021 Genomic Medicines & Rare DiseaseDate:   Thursday, April 1Time:   Krystal leadership will participate in a panel discussion at 4:00pm ET     2021 Virtual Cell & Gene Meeting on the MediterraneanDate:   Tuesday, April 6 – Friday, April 9Time:   Company presentations will be available to view on-demand throughout the entirety of the conference. Please visit www.meetingonthemed.com for full information, including registration.About Krystal BiotechKrystal Biotech, Inc. (NASDAQ:KRYS) is a pivotal-stage gene...